Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Double-blind Placebo-Controlled Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)

NCT07100743 is registered in ClinicalTrials.gov with National University of Malaysia as lead sponsor.

NCT NCT07100743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07100743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Double-blind Placebo-Controlled Trial of Multi-Strain Probiotic Supplementation (Hexbio®) in Malaysian Patients With Drug-Resistant Epilepsy (ProbE)
Lead sponsor
National University of Malaysia
Phase
Not applicable
Overall status
Active, not recruiting
Start date
April 3, 2023
Completion date
March 2, 2026
Enrollment
78 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsies refractory